Immoral policing' hindering tourism growth in DK, laments AB Ibrahim

Mysuru, Jan 11: Accusing the Congress and other opposition parties of pursuing “vote bank politics” on the Citizenship (Amendment ) Act (CAA), Kannada littérateur and Saraswathi Samman awardee S L Byrappa accused the party of misleading the people on the issue.

Speaking to media persons here on Friday, Mr Bhyrappa said that Congress was adopting the divide and rule policy of the British, who had created a rift between the Hindus and the Muslims to break their unity during the freedom struggle.

Udupi, Apr 5: Excise Department has formed a special patrol teams to check the illegal sale of liquor in the district during the lockdown period.

All liquor stores are closed till April 14 in view of the lockdown to contain Covid-19 spread. However, reports of liquor being sold illegally have come to the notice of the Excise Department.

In a stern warning, the department has stated that officials will verify the closing and opening stock at the liqour stores and if any discrepancy is found the violators will be penalised. The department has received over 20-30 calls regarding the illegal sales.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.